We compared the expression of cell adhesion molecules (CAMs) 
CD56 (neural cell adhesion molecule [NCAM]
) is a member of the immunoglobulin superfamily of homotypic cell adhesion molecules (CAMs). 1 CD56+ lymphocytes consist mainly of natural killer (NK) and cytotoxic T cells (CTLs), which are activated by surface CAMs of CD2 (leukocyte function antigen [LFA2]), CD11a (LFA1 alpha), and very late antigen (VLA)4 and their ligands. [2] [3] [4] [5] NK cells are activated by interleukin (IL)-2, IL-12, and IL-15 and their IL-2 beta and gamma and IL-12 receptors. They increase an innate immune response and induce cytolysis by production and activation of interferon-gamma and cytotoxic granule proteins. 6, 7 T-cell-restricted intracellular antigen (TIA)1, perforin, and granzymes, which work mainly as a cytotoxic granule protein, are included in the cytoplasmic granules of NK cells and CTLs. [8] [9] [10] As well as these proteins, it is known that stimulation through the CD95 (Fas)-CD95L (Fas ligand) pathway of NK cells induces activation of the IL-1 beta-converting enzyme and cysteine protease 3 (CPP32) of target cells and has an important role in target cell lysis and its nuclear fragmentation, so-called apoptosis. [11] [12] [13] High expression of Bcl2-associated X protein (Bax) of NK cells and large granular lymphocytes (LGLs) is known to promote apoptosis, but Bcl2 protein inhibits this type of cell death and promotes cell survival by controlling the aforementioned proteinase cascade of the IL-1 beta-converting enzyme, CPP32, and their family. 14 The tumor suppressor gene wild-type p53 also is involved in the DNA repair machinery of cells in cooperation with Bcl2, Bax, and other products. 15 However, mutant p53 leads to loss of the apoptosis-inducing capacity of wild-type p53.
CD56+ NK/T-cell lymphoma is considered to be a tumor of NK cell and NK-like CTL lineages and frequently shows angiocentric and angiodestructive features and massive fibrinoid necrosis. 16 , 17 Ng et al 18 strongly suggested that the histologic apoptosis of CD2 (LFA2)-negative and CD56+ lymphoma is influenced by expression of TIA1, perforin, and granzyme B of the lymphoma cells. It also has been suggested that systemic tissue damage of LGL leukemia and NK-cell lymphoma is influenced by the effect of CD95L (Fas ligand)-positive neoplastic cells. 19 Lorenzen et al 20 also demonstrated that expression of Bcl2 of nasal NK/T-cell lymphoma was not associated with apoptotic indices (AI) detected by the in situ terminal deoxynucleotidyl transferase (TdT)-mediated digoxigenin-deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) method and the ratio of MIB1-positive proliferating cells. Takeshita et al 21 previously reported 16 cases of cutaneous CD56+ NK/CTL lymphoma with rare Epstein-Barr virus infection, and 10 cases showed angiodestructive features. In the present study, we examined and analyzed statistically which kinds of CAMs, cytotoxic granule-and apoptosisrelated proteins influenced the tissue necrosis and how this occurred by comparing cases of cutaneous CD56+ NK/Tcell lymphoma with and without angiodestruction and tissue necrosis.
Materials and Methods

Patients
A total of 150 patients with primarily skin-involving lymphoma were examined, and 16 cases of CD56+ lymphoma were selected. Their clinical data were obtained from hospital charts. The patients were staged according to the Ann Arbor classification. The actuarial overall survival was evaluated by the Kaplan-Meier method and analyzed by the log-rank, Wilcoxon, and Cox-Mantel methods.
Histology and Immunohistochemistry
Tissue specimens were fixed with 20% formalin, embedded in paraffin, and stained with H&E and Giemsa solution. For immunohistology, a battery of monoclonal and polyclonal antibodies ❚Table 1❚ was applied by the peroxidase-conjugated avidin-biotin complex method to the formalin-fixed samples and/or tissue specimens frozen in liquid nitrogen. To detect monoclonal antibodies CD11a, CD16, CD49d, CD54, CD58, CD106, CD122, CD95, CD95L, and Bax, catalyzed signal amplification (DAKO, Copenhagen, Denmark) 22 was used after heating the slides in a 1-mmol/L solution of EDTA (pH 8.0) in a 1,200 W microwave oven (H2800, Energy Beam Sciences, Agawam, MA). The peroxidase reaction was developed using diaminobenzidine and hydrogen peroxide. To confirm the results from the formalin-fixed samples, the aforementioned antibodies in the frozen tissue of 8 cases in each group also were examined.
Electron Microscopy
Electron microscopy was performed on samples from 5 cases in each group. The cut tissue specimens were fixed in 3% phosphate-buffered glutaraldehyde, pH 7.4, and postfixed in a 1% osmium tetroxide (OsO 4 ) solution. After the specimens were embedded in epoxy resin, the ultrathin sections were stained with uranyl acetate and lead citrate and examined by using a JEM 100CX electron microscope (Nihon Densi, Tokyo, Japan). More than 50 lymphoid cells were examined in each patient.
Terminal Deoxynucleotidyl Transferase-Mediated DigoxigeninDeoxyuridine Triphosphate Nick End Labeling
Tissue sections were incubated with 20 µg/mL proteinase K for 20 minutes, and the following procedures were performed by using the ApopTag Plus kit (Oncor, Gaithersburg, MD) 23 : the sections were incubated for 1 hour in a solution containing TdT, digoxigenin-labeled deoxyuridine triphosphate, and deoxyadenosine triphosphate. The sections were then treated with peroxidase-labeled anti-digoxigenin antibody for 30 minutes. The reaction products were developed by 3-3´ diaminobenzidine solution with hydrogen peroxide.
DNA Analysis
Specimens from 4 cases from each group were analyzed. Extracted DNA from the frozen tissue of 8 patients was digested with EcoRI, BamHI, and HindIII, subjected to electrophoresis in 0.8% agarose gel, transferred to a nitrocellulose filter by the Southern blot method, and hybridized with phosphorus 32-labeled DNA probes. Rearrangements of the T-cell receptor (TcR) and immunoglobulin genes were examined by using probes that included the first J region (J delta 1), the constant region of the TcRC beta gene (C beta), and the joining region of heavy chain (JH). 24 In Situ Hybridization of Epstein-Barr Virus-Encoded RNA Deparaffinized tissue sections were digested with proteinase K and hybridized overnight in a solution of 50% formamide containing digoxigenin-labeled Epstein-Barr virus-encoded RNA (EBER) 1 and 2 oligonucleotide probes. Horseradish peroxidase-conjugated anti-digoxigenin antibody was applied to detect the product of hybridization (Rembrandt, Amsterdam, the Netherlands). 25 The reaction was developed by incubation with 3-amino-9-ethyl carbazole substrate.
Statistical Analysis
To confirm the difference of the immunophenotypes and AI between the 2 groups, more than 1,000 mononuclear cells were counted in the immunostained sections of each antibody and TUNEL-positive cells in each case under microscopy. More than 30% of mononuclear cells immunoreactive to each antibody were estimated to be positive. Mean positive ratios of the examined antibodies and AI were analyzed by using the Student t test.
Results
Histologic findings, expressions of cell surface markers, and CAMs of tumor cells are shown in ❚Table 2❚. Expression of cytotoxic granule proteins, apoptotic indices and apoptosis-related proteins, TcRC beta gene, and EBERs are shown in ❚Table 3❚.
CD56+ Lymphoma With Angiodestruction (n = 10)
In the 16 cases examined, 10 cases consisted of pleomorphic large lymphoma cells with irregular nuclear contour and stippled chromatin, showing angiocentric and angiodestructive features and patchy and massive fibrinoid necrosis ❚Image 1❚. Histiocytic reaction with and without granuloma formation was found. Many apoptotic bodies frequently were found and were clustered in each case ❚Image 2❚. Eight of the cases presented features of lobular panniculitis in the subcutis, and 6 cases showed patchy and diffuse dermal invasion by the lymphoma cells. Deep skin ulceration was present in 8 of the cases.
CD56+ Lymphoma Without Angiodestruction (n = 6)
The remaining 6 cases showed diffuse and monomorphic dermal and/or subcutaneous invasion by lymphoma cells with less nuclear pleomorphism ❚Image 3❚. Angiocentric and CSA, catalyzed signal amplification; EBER, Epstein-Barr virus-encoded RNA; HRP, horseradish peroxidase; ICAM, intercellular adhesion molecule; ICE, IL-1 beta-converting enzyme; IL, interleukin; LFA, leukocyte function antigen; NCAM, neural cell adhesion molecule; NK, natural killer; TIA, T-cell restricted intracellular antigen; TdT, terminal deoxynucleotidyl transferase; TNF, tumor necrosis factor; VCAM, vascular cell adhesion molecule; VLA, very late antigen. * These antibodies are detected in formalin-fixed and frozen sections by the CSA system and the streptavidin-biotin complex peroxidase method.
angiodestructive features of the lymphoma cells and massive necrosis were absent. Four cases had large lymphoma cells with an oval nuclear contour, and the other 2 cases consisted of medium-sized to large blastic cells with fine chromatin. Histiocytic reaction was mild. Apoptotic bodies occasionally were encountered in 2 of the cases. No skin ulceration was detected in any case, and focal erosion of the tumor top was found in 2 cases.
Ultrastructural Findings (n = 10)
Infiltrating large atypical lymphocytes of the 5 cases examined with angiodestruction had some electron-dense membrane-bound granules (160-300 nm) in the abundant cytoplasm. Mitochondria and endoplasmic reticulum were clustered near the granules. Cells with nucleolysis and degenerative cytoplasm were in clusters. Atypical lymphoid cells with irregular or elongated nuclei and heterochromatin were found near apoptotic cells, and some of them had dense core granules in the cytoplasm ❚Image 4❚. On the other hand, atypical lymphocytes of only 2 cases without angiodestruction had a few dense-core granules in the cytoplasm, and abundant glycogen granules were found in the atypical lymphocytes of 4 cases.
Immunohistochemistry and Apoptosis
Lymphoma cells of all 16 cases showed positive expression of CD56 (Leu19) and/or CD56 (NCAM1) ❚Image 5A❚ but were negative for CD16 (Leu11) and CD57 (Leu7). 
CD56+ Lymphoma With Angiodestruction (n = 10)
CD3 epsilon was detected in the lymphoma cells of 9 cases, and TdT-positive lymphoma cells were absent in each case. CD4+ and CD8-lymphoma cells were found in 5 cases, CD4-and CD8+ in 3, and CD4-and CD8-in 2 cases. CD2 (LFA2), CD11a (LFA1 alpha), and CD49d (VLA4) were detected in the lymphoma cells of 10, 8, and 7 cases, respectively. Their ligands CD58 (LFA3), CD54 (ICAM1), and CD106 (VCAM1) were detected in the lymphoma cells and vascular endothelium of 7, 8, and 5 cases, respectively. Lymphoma cells of 9 cases were positive for CD122 (IL-2 beta receptor). TIA1, perforin, and granzyme B were strongly positive in the cytoplasm of the lymphoma cells of almost all cases ❚Image 5B❚. In the TUNEL examination for all 10 cases, the nuclear apoptotic signal was scattered and partly clustered near the necrotic lesion and involved site, and AI constituted 1.3% to 5.6% of the mononuclear cells (mean, 3.7%) ❚Image 6A❚. CD95 (Fas) and CD95L (FasL) were found in the lymphoma cells of 8 cases each. CD95L (FasL) also was positive for endothelial cells ❚Image 6B❚. Bax-positive lymphoma cells were found in 9 cases, while Bcl2 was absent in the tumor cells of all 10 cases. CPP32 was found in the cytoplasm of the lymphoma cells of 7 cases, and p53 (DO7) was found in the nuclei of 5 cases. MIB1-positive tumor cells were detected in 9 cases.
CD56+ Lymphoma Without Angiodestruction (n = 6)
CD3 epsilon-and TdT-positive lymphoma cells were found in 4 and 3 cases, respectively. CD4+ lymphoma was found in 4 cases, CD4-and CD8+ lymphoma in 1 case, and ❚Image 3❚ Specimen from scalp. Dermal infiltration by monomorphic large blastic lymphoma cells with round nuclei and coarse chromatin. Only a few apoptotic bodies are detected (H&E, ×400). and 3 cases, respectively, and their reaction was weak. In the TUNEL examination for all 6 cases, an apoptotic signal was found in a few cells of 4 cases or in some scattered cells of the other 2 cases. AI counted 0.2% to 2.1% of all the mononuclear cells (mean, 1.0%) ❚Image 7B❚. Lymphoma cells of 5 cases showed positive expression of CD95L (FasL), while only 1 case was positive for CD95 (Fas). Baxpositive lymphoma cells were found in 5 cases and Bcl2-positive cells in 3 cases. CPP32-positive lymphoma was found in 1 case, and p53 (DO7) was found in 3 cases. MIB1-positive tumor cells were found in 2 cases.
Statistical Analysis
The mean of immunoreactivity to examined antibodies CD2, CD3 epsilon, CD58, CD54, CD122, TIA1, granzyme B, AI, CD95, CPP32, and MIB1 for the 10 cases with angiodestruction showed a significantly higher percentage (P < .05) than those of the 6 cases without angiodestruction. Bcl2-positive cells in the cases with angiodestruction were significantly lower (P < .05) than those of cases without angiodestruction.
DNA Analysis
Four cases in each group were examined (Table 3) . Two cases with angiodestruction and 3 cases without angiodestruction had rearranged J delta 1 and TcRC beta genes. Lymphoma cells of the 5 cases were positive for CD3 epsilon. No rearrangement of the immunoglobulin JH gene was detected in the 8 cases.
Detection of EBER
Only 2 cases with angiodestruction showed diffuse infiltration of lymphoma cells with intranuclear signal of EBERs by in situ hybridization (Table 3 ). No examination of TcR genes was performed on these 2 cases because of lack of fresh material.
Clinical Findings and Prognosis
CD56+ Lymphoma With Angiodestruction (n = 10)
The 10 patients varied in age from 7 to 80 years (median, 66 years) ❚Table 4❚. Eight patients were female, and 2 were male. Localized purple skin tumors larger than 2 cm were detected in 6 patients and systemic multiple tumors in 4 patients. Five patients were classified into stages IE or IIE ❚Image 4❚ Ultrastructural findings of CD56+ lymphoma with angiodestruction. Some dense core granules are detected in lymphoid cells with slightly irregular nuclei. Lymphocytes with angulated nuclei, heterochromatin, and swollen mitochondria are found on the right. Cells with nucleolysis and abundant glycogen granules and an indistinct cell membrane are present in the lower center (× 2,800).
and the other 5 patients into stage IV. Although all patients received chemotherapy and radiotherapy, 6 died of the disease within 2 to 40 months.
CD56+ Lymphoma Without Angiodestruction (n = 6)
The ages of the 6 patients ranged from 58 to 85 years (median, 79 years) ( Table 4) . Five patients were men. Two patients had localized skin tumors larger than 3 cm, and the other 4 showed systemic skin tumors. Two patients showed leukemic changes (3% and 20% of the mononuclear cells), bone marrow invasion (27% and 58% of the mononuclear cells), and systemic lymphadenopathy. Four patients were classified into stage IE and the other 2 into stage IV. All patients were treated by chemotherapy and radiotherapy. In 2 patients without leukemia at presentation, leukemic changes, bone marrow invasion, and systemic lymphadenopathy developed between 15 and 19 months after initial hospitalization. All but 1 patient died of the disease within 3 to 22 months. By the Kaplan-Meier method, patients with angiodestruction tended to show a better clinical course than patients without angiodestruction from 2 to 4 years, but no significant difference was found by the log-rank, Wilcoxon, and Cox-Mantel analyses. 
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❚Image 6❚ CD56+ lymphoma with angiodestruction. A, Some clustered mononuclear cells have intranuclear signal of apoptosis by the terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine triphosphate nick end labeling method (×300). B, CD95L (Fas ligand) is detected in lymphoma cells and vascular endothelium (catalyzed signal amplification system, ×350).
Discussion
We presented 2 different histologic groups of primarily skin-involving CD56+ lymphoma with tumor formation, one showing angiocentric and angiodestructive features by large lymphoma cells and massive fibrinoid necrosis and the other with none of these histologic findings. DiGiuseppe et al 26 demonstrated that 4 cases of CD56+ blastic NK cell leukemia/lymphoma, having few azurophilic granules of the cytoplasm, showed multiple skin lesions without angiodestruction. Petrella et al 27 also reported that cutaneous CD56+ large cell lymphoma of 7 patients, showing frequent bone marrow involvement and less angiodestruction, was mainly CD4+ and negative for CD2, CD16, TIA1, and granzyme B. We further reported these cases of skin-involving CD56+ blastic lymphoma, showing occasionally positive nuclear signal of TdT and frequently rearrangement of the TcRC beta gene. The disease characteristics of cases without angiodestruction in our study were consistent with those of the cases reported by DiGiuseppe et al 26 and Petrella et al. 27 Since EBER-positive lymphoma cells were detected in only 2 cases with angiodestruction, it was supported that EpsteinBarr virus infection had less influence on the histologic findings of angiodestruction and massive necrosis in cutaneous CD56+ NK/T-cell lymphoma.
NK cells and CTLs possess intracytoplasmic electrondense core granules, which include cytotoxic granule-related proteins, TIA1, perforin, and granzymes. Ng et al 18 reported frequent expression of TIA1, granzyme, and perforin of almost all 24 cases of nasal CD56+ NK/T-cell lymphoma. Felgar et al 28 commented that the antibody of TIA1 was a more useful marker to identify the lymphoid neoplasm of NK cell or CTL origin than perforin and granzymes, since TIA1 was expressed in activated and nonactivated NK cells and CTLs. In the present study, 6 cases without angiodestruction were negative for TIA1. Perforin and granzyme B were weakly positive to lymphoma cells in 4 and 3 cases, respectively. Ultrastructurally, tumor cells of 3 of the 5 cases examined showed few electron-dense core granules in the cytoplasm. On the other hand, the 10 cases with angiodestruction, having the aforementioned 3 cytotoxic granule proteins and many dense core granules, presented angiodestructive features and massive fibrinoid necrosis. In cases of cutaneous CD56+ NK/T-cell lymphoma, cytotoxic granule proteins in the electron-dense core granules, especially TIA1 and granzyme B, might have an influence on angiodestruction and tissue necrosis. Our results further demonstrate the view that TIA1 is not a constant marker of NK/T-cell lymphoma.
In all 6 cases without angiodestruction, the lymphoma cells mostly were negative for CD122 (IL-2 beta receptor). On the other hand, CD122 (IL-2 beta receptor)-positive lymphoma cells were detected in 9 of 10 cases with angiodestruction. IL-2 has an important role in the maturation and proliferation of NK cells and other T cells. Umehara and Bloom 29 reported that prominent proliferation and cytotoxic activity of peripheral blood NK cells cultured with IL-2 for 48 hours were blocked by the antibody CD122 (IL-2 beta receptor). Our findings support the view that activation by IL-2 ❚Image 7❚ CD56+ lymphoma without angiodestruction. A, Some small T-cell restricted intracellular antigen (TIA)1-positive lymphocytes are scattered. Large lymphoma cells are negative for TIA1 (avidin-biotin complex peroxidase method). B, A few apoptotic signals are detected in tumor tissue (terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine triphosphate nick end labeling method, ×350).
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and IL-2 beta receptor might have an influence on the characteristic histology of angiodestruction and tissue necrosis in this type of lymphoma, using cytotoxic granule proteins. CD2 (LFA2), CD11a (LFA1 alpha), and CD49d (VLA4) are the main CAMs of NK cells and CTLs. These 3 molecules and the ligands CD58 (LFA3), CD54 (ICAM1), and CD106 (VCAM) have an important role in the binding and migration of IL-2-and IL-12-activated NK cells in IL-1-pretreated endothelial cells in vitro. 30 Leca et al 31 reported that gamma delta T cells expressed CD106 (VCAM1) by a proteolytic cleavage process involving Zn 2+ -activated metalloprotease in vitro. We found that the 10 cases with angiodestruction had a significantly (P < .05) higher ratio of CD2 (LFA2), CD58 (LFA3), and CD54 (ICAM1) than those cases without angiodestruction. CD58 (LFA3), CD54 (ICAM1), and CD106 (VCAM1) also were positive for vascular endothelium in the cases with angiodestruction. On the other hand, lymphoma cells of the cases without angiodestruction mostly were negative for CD2 (LFA2), CD58 (LFA3), CD54 (ICAM1), and CD106 (VCAM1), presenting minimal angiodestruction and tissue necrosis. There have been some reported cases of CD2 (LFA2)-negative and CD56+ large blastic lymphoma without angiodestruction of the skin. 27 The 3 CAMs and their ligands might be important to produce angiodestruction and tissue necrosis of cutaneous CD56+ lymphoma by inducing adhesion in each tumor cell and endothelial cells and activating intracytoplasmic cytolytic proteins in the following procedures.
Tanaka et al 19 reported that soluble CD95L (FasL) was detected at a high level in the serum of patients with NK-cell and LGL leukemia/lymphoma but not in the serum of patients with other types of malignant lymphoma. Ohshima et al 32 also reported that CD95 (Fas) was detected in lymphoma cells and reactive cells in cases of nasal CD56+ lymphoma. They suggested that the CD95 (Fas)-CD95L (FasL) pathway might be responsible for angiodestruction and tissue necrosis of NK cell and LGL leukemia/lymphoma. Ng et al 33 also reported that nasal CD56+ lymphoma of 27 cases frequently coexpressed CD95 (Fas) and CD95L (FasL), but their expression did not correlate with AI. Izban et al 34 demonstrated that severe tumor cell apoptosis, which was detected by the TUNEL method, was induced by treatment of antibody CD95 (Fas) in CPP32-positive giant cells of 2 of the 3 Hodgkin disease cell lines, and its apoptosis was inhibited by pretreatment with the CPP32 inhibitor. In our 16 cases, morphologic apoptotic cells frequently were found in cases with angiodestruction, and AI showed a significantly (P < .01) higher score than in the cases without angiodestruction. CD95L (FasL) frequently was expressed in this lymphoma in almost all cases. The cases with angiodestruction consisted of significantly (P < .05) higher CD95 (Fas)-positive and CPP32-positive lymphoma cells than cases without angiodestruction. These results support the view that coincident expression of CD95 (Fas), CD95 (FasL), and CPP32 might activate an apoptotic pathway and induce severe apoptosis in cutaneous CD56+ lymphoma.
CD56 is a homotypic CAM of NK and cytotoxic T cells. In the present study, CD2 (LFA2), CD11a (LFA1), CD49d (VLA4), and CD95 (Fas) and their ligands frequently were positive for lymphoma cells and vascular endothelial cells in cases with angiodestruction. It has been supported that granzyme B secreted by CTLs, as well as their CD95 (Fas)-CD95L(FasL) pathway, has an important role in cleavage and activation of CPP32 in the processes of target cell lysis of CTLs and CTL lines. 35 Autocrine and paracrine mechanisms of cell death by CAMs, cytotoxic granule proteins, and apoptosis-related proteins might influence the characteristic histologic findings of cutaneous CD56+ lymphoma.
Armant et al 36 reported that IL-2 and IL-7 protected peripheral blood NK cells from glucocorticoid-induced apoptosis and enhanced Bcl2 expression of NK cells, and they suggested the presence of a Bcl2-dependent survival pathway of NK cells. Intracytoplasmic high Bcl2 and low Bax expression have been considered to protect from apoptosis and induce cell proliferation in some kinds of human cancers. 37 However, since B-cell lymphoma of 116 cases showed an inverse relationship between Bcl2 expression and proliferating activity, it has been suggested that Bcl2 retarded entry in the cell cycle and inhibited apoptosis of the lymphoma cells. 38 Lorenzen et al 20 demonstrated that Bcl2 expression was not associated with the MIB1-positive proliferating ratio and AI of 30 cases of nasal NK/T cell lymphoma. In our study, Bax-positive lymphoma cells were found in 14 of 16 cases of CD56+ NK/T-cell lymphoma. Bcl2 expression of the lymphoma cells was detected in only 3 cases without angiodestruction, but expression did not correlate with the MIB1-positive proliferating ratio and AI of the 3 cases. Our immunohistologic results support the view that frequent Bax expression and negative Bcl2 are typical findings of cutaneous CD56+ lymphoma with angiodestruction, and Bcl2 expression is not associated with the proliferating ratio and is not an important inhibitor of apoptosis in this type of lymphoma.
Brambilla et al 37 also reported that mutant p53 protein (DO7) has an influence on expression of the aforementioned 2 Bcl-related proteins and decreased apoptosis of the tumor cells of neuroendocrine lung cancer. Nakamura et al 39 reported on expression of p53 (DO7) and Bcl2 in 10 cases of CD56+ extranasal lymphoma, but no cooperative expression of the 2 antibodies was found. Furthermore, Natkunam et al 40 demonstrated that cutaneous CD56+ lymphoma of 12 cases showed less expression of p53 (DO7) and a high proliferating ratio of the neoplastic cells. Of our 16 cutaneous cases, p53 (DO7)-positive lymphoma cells of 8 cases were independent of expression of the 2 Bcl-related proteins and proliferating ratio of the tumor cells. These findings indicate that p53 (DO7) might have less influence on the Bcl2 and Bax-related apoptotic pathway of cutaneous CD56+ NK/T-cell lymphoma and suggest that expression of p53 (DO7) and Bcl2 in this type of lymphoma is not associated with the proliferating ratio and AI of the mononuclear cells.
